Risk stratification for therapeutic management and prognosis

Heart Fail Clin. 2009 Jul;5(3):437-55, vii. doi: 10.1016/j.hfc.2009.02.010.

Abstract

In coronary artery disease (CAD), cardiac magnetic resonance (CMR) imaging can integrate several types of pulse-sequence examinations (eg, myocardial perfusion, cine wall motion, T2-weighted imaging for myocardial edema, late gadolinium enhancement, and CMR angiography) that can provide anatomic, functional, and physiologic information about the heart in a single imaging session. Because of this ability to interrogate myocardial physiology using different pulse sequence techniques within a single CMR session, this technique has been recognized increasingly in many centers as the test of choice for assessing patients who present with cardiomyopathy of undetermined cause. This article first reviews the current evidence supporting the prognosticating role of CMR in assessing CAD and then discusses CMR applications and prognostication in many non-coronary cardiac conditions.

Publication types

  • Review

MeSH terms

  • Amyloidosis / complications
  • Amyloidosis / diagnosis
  • Cardiomyopathies / diagnosis*
  • Cardiomyopathies / etiology
  • Cardiomyopathies / therapy
  • Chagas Cardiomyopathy / diagnosis
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / diagnosis*
  • Coronary Artery Disease / therapy
  • Endomyocardial Fibrosis / complications
  • Endomyocardial Fibrosis / diagnosis
  • Fabry Disease / complications
  • Fabry Disease / diagnosis
  • Humans
  • Iron Overload / complications
  • Iron Overload / diagnosis
  • Magnetic Resonance Imaging / methods*
  • Magnetic Resonance Imaging, Cine / methods
  • Myocardial Ischemia / diagnosis
  • Myocardial Ischemia / etiology
  • Myocardial Perfusion Imaging / methods
  • Myocarditis / complications
  • Myocarditis / diagnosis
  • Prognosis
  • Risk Assessment / methods
  • Sarcoidosis / complications
  • Sarcoidosis / diagnosis